the Coronary Artery Surgery Study (CASS) randomized trial. New Engl J Med 1985; 312:1665–71.
16. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. New Engl J Med 1984; 311: 1333–9.
17. Healy B. The Yentl syndrome. New Engl J Med 1991; 325:274–5.
18. U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Memo from the Director of Office of Drug Evaluation I to Carl Peck, Center for Drug Evaluation and Research: Studies of older patients in NDAs for NMEs approved in 1988. Washington, D.C., September 8, 1989.
19. Hamilton JA. Guidelines for avoiding methodological and policymaking biases in gender-related health research. In: Report of the Public Health Service Task Force on Women’s Health Issues, Vol. II. Rockville, Md: U.S. Public Health Service, 1985:IV-54-IV-64.
20. Peto R. Clinical trial methodology. Biomed Pharmacother 1978; 28: 24–36.
21. Simon R. Patient subsets and variation in therapeutic efficacy. Br J Clin Pharmacol 1982; 14:473–82.
22. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80(l):21–9.
23. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339:1–15, 71–85.
24. Davis CE, Leffingwell D. Empirical bayes estimates of subgroup effects in clinical trials. Controlled Clin 1990; 11:347–53.
25. Yusuf S, Wittes J, Probstfield J, Tyroler H. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. J Am Med Assoc 1991; 266:93–8.
26. Herbst AL, Ulfelder H, Postkanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. New Engl J Med 1971; 284:978–81.
27. Institute of Medicine. Patient outcomes research teams: managing conflict of interest. Donaldson MS, Capron AM, eds. Washington, D.C.: National Academy Press, 1991.
28. Collins R, Gray R, Godwin J, Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effect: the need for systematic overviews. Stat Med 1987; 6:245–50.